TM
TOI icon

Triatomic Management’s The Oncology Institute TOI Stock Holding History

Triatomic Management’s Portfolio TOI Stock Details TOI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-802,965
Closed -$369K – 5
2024
Q2 		$369K Sell
802,965
-81,724
-9% -$69.8K 10.89% 5
2024
Q1 		$1.4M Hold
884,689
– – 2.61% 11
2023
Q4 		$1.8M Sell
884,689
-20,000
-2% -$34.7K 2.3% 10
2023
Q3 		$1.27M Hold
904,689
– – 0.88% 23
2023
Q2 		$498K Buy
904,689
+94,544
+12% +$50K 0.51% 33
2023
Q1 		$549K Buy
810,145
+292,666
+57% +$373K 0.37% 38
2022
Q4 		$854K Buy
517,479
+151,800
+42% +$426K 0.72% 21
2022
Q3 		$1.69M Hold
365,679
– – 0.97% 21
2022
Q2 		$1.85M Sell
365,679
-62,421
-15% -$455K 1.7% 14
2022
Q1 		$3.05M Buy
428,100
+28,100
+7% +$190K 2.48% 12
2021
Q4 		$3.9M Buy
+400,000
New +$3.56M 2.39% 15

Other funds holding TOI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TAS
TIFF Advisory Services Radnor, Pennsylvania $408M AUM 20.34% 1-Year Est. Return
CI
Cincinnati Insurance Fairfield, Ohio $6.62B AUM 18.42% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Triatomic Management's TOI Position: Q3 2024 in Review

Triatomic Management sold out of The Oncology Institute (TOI) in Q3 2024, closing a stake of 802,965 shares — an estimated $369K sold.

Triatomic Management first reported a position in TOI in Q4 2021 and held it in 11 quarters. The position peaked at $3.9M in Q4 2021. 34 funds tracked by Wall St. Rank hold TOI as of Q3 2024.

  • Triatomic Management reported no remaining The Oncology Institute position as of Q3 2024 after selling out during the quarter.
  • Triatomic Management sold 802,965 The Oncology Institute shares in Q3 2024, an estimated $369K.
  • Triatomic Management first reported a position in The Oncology Institute in Q4 2021 and held it in 11 quarters.
  • Triatomic Management's The Oncology Institute position peaked at $3.9M in Q4 2021.
  • 34 funds tracked by Wall St. Rank held The Oncology Institute as of Q3 2024.

Based on Triatomic Management's 13F filing for Q3 2024.